Summary
High levels of ammonia in blood and brain due to metabolic disorders are associated with neurological abnormalities. Although the mechanism of ammonia toxicity at the CNS level is still unknown, alterations in brain energy metabolism, in neurotransmitter function and direct effects on nervous impulse have been proposed. In most hyperammonemic conditions morphological changes in the liver and brain have been demonstrated, especially in mitochondria, endoplasmic reticulum and lysosomes, together with an accumulation of intracellular lipids. The treatment of hyperammonemias is uncertain and mostly directed to reduce the level of circulating ammonia; there is no current therapy aimed to counteract the molecular effects of ammonia. Administration of carnitine prevents acute ammonia toxicity and enhances the efficacy of ammonia elimination as urea and glutamine. In addition the cytotoxic effects of ammonia, possibly arising from lipid peroxidation, are ameliorated by carnitine. These data indicate the feasibility of utilization of carnitine in the therapy of human hyperammonemic syndromes, both for reducing the levels of ammonia and preventing its toxic effects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Duffy TE and Plum F: Hepatic encephalopathy. In (Arias I, Popper H, Schachter D and Shafritz D, eds) The Liver: Biology and Pathobiology. New York, Raven Press, pp 693–795, 1982.
Walser M: Urea cycle disorders and other hereditary hyperammonemic syndromes. In (Stanbury JB, Wyngaarden JB and Fredrickson DS, eds) The Metabolic Basis of Inherited Diseases. New York, McGraw-Hill, pp 402–438. 1982.
Rosenberg, LE: Disorders of propionate, methylmalonate and cobalamin metabolism. In (Stanbury JB, Wyngaarden JB and Fredrikson DS, eds) The Metabolic Basis of Inherited Diseases. New York, McGraw-Hill, pp 411–429, 1978.
Coulter DL and Allen RJ: Hyperammonemia with valproic acid therapy. J. Pediat. 99: 317–319, 1981.
Glasgow AM: The role of hyperammonemia in Reye’s syndrome. J. Natl. Reye’s Syndrome Found. 4: 24–31, 1984.
Hindfelt B, Plum F and Duffy TE: Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J. Clin. Invest. 59: 386–396. 1977.
McCandless DW and Schenker S: Effect of acute ammonia intoxication on energy stores in the cerebral reticular activating system. Exp. Brain Res. 44: 325–330, 1981.
Hamberger A, Hedquist B and Nistrom B: Ammonium ion inhibition of evoked release of endogenous glutamate from hippocampal slices. J. Neurochem. 33: 1295–1302, 1979.
Ferenci P, Jacobs R, Pappas SC, Schafer DF and Jones EA: Enzymes of cerebral GABA metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: Evidence for decreased cerebral GABA-transaminase activity. J. Neurochem. 42: 1487–1490, 1984.
Raabe W and Lin S: Ammonia, postsynaptic inhibition and CNS-energy state. Brain Res. 303: 67–76; 1984.
Conn HO and Lieberthal MN: The Hepatic Coma Syndromes and Lactulose. Baltimore, Williams and Wilkins, 1979.
Campbell AGM, Rosenberg LE, Snodgrass PJ and Nuzum CT: Ornithine transcarbamylase deficiency: a cause of lethal neonatal hyperammonemia in males. New England J. Med. 288: 1–6, 1973.
Partin JC, Partin JS, Schubert WK and McLaurin RL: Brain ultrastructure in Reye’s syndrome encephalopathy and fatty alteration of the viscera. J. Neuropathol. Exp. Neurol. 34: 425–444, 1975.
Popper H: Introduction. In (Keppler D, Popper H, Bianchi L and Reutter W, eds) Mechanisms of Hepatocyte Injury and Death. Lancaster, MTP Press, pp 11–30, 1984.
Partin JC, Schubert WK and Partin JS: Mitochondrial ultrastructure in Reye’s syndrome: Encephalopathy and fatty degeneration of the viscera. New England. J. Med. 258: 1339–1343, 1971.
O’Connor JE, Costell M and Grisolía S. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine. Biochem. Biophys. Res. Commun. 145: 817–824, 1987.
O’Connor JE, Ribelles M and Grisolía S: Potentation of hyperammonemia by sodium benzoate: a note of caution. Eur. J. Pediatr. 138: 186–187, 1982.
O’Connor JE, Guerri C and Grisolía S: Protective effect of ethanol on acute ammonia intoxication in mice. Biochem. Biophys. Res. Commun. 104: 410–415, 1982.
O’Connor JE, Guerri C and Grisolía S: Protective effect of tert-butanol on hyperammonemia. New England J. Med. 347: 254, 1982.
Bremer J: Carnitine: Metabolism and functions. Physiol. Rev. 63: 1420–1480, 1983.
Hulsmann WC, Siliprandi D, Ciman M and Siliprandi N: Effect of carnitine on the oxidation of 2-oxoglutarate to succinate in the presence of acetoacetate or pyruvate. Biochim. Biophys. Acta 93: 166–168, 1964.
O’Connor JE, Costell M and Grisolía S: Protective effect of L-carnitine on hyperammonemia. FEBS Lett. 166: 331–334, 1984.
O’Connor JE, Costell M and Grisolía S: Prevention of ammonia toxicity by L-carnitine: Metabolic changes in brain. Neurochem. Res. 9: 563–569, 1984.
O’Connor JE, Costell M, Miguez MP, Portoles M and Grisolía S: Effect of L-carnitine on ketone bodies, redox state and free aminoacids in the liver of hyperammonemic mice. Biochem. Pharmacol. 36: 3169–3173, 1987.
Coates PM, Hale DE, Stanley CA and Glasgow AM: Systemic carnitine deficiency simulating Reye’s syndrome. J. Pediatr. 105: 679, 1984.
Roe CP and Bohan TP: L-Carnitine therapy in propionicacidemia. Lancet 1: 1411–1412, 1982.
Ohtani Y, Endot F and Matsuda I: Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J. Pediatr. 101: 782–785, 1982.
Costell M, Miguez MP, O’Connor JE and Grisolía S: Effect of hyperammonemia on the levels of carnitine in mice. Neurology 37: 804–808, 1987.
O’Connor JE, Renau-Piqueras J and Grisolía S: Effects of urease-induced hyperammonemia in mouse liver. Ultrastructural, stereologic and biochemical study. Virchows Arch. (Cell Pathol.) 46: 187–197, 1984.
Renau-Piqueras J, O’Connor JE, Baguena-Cervellera R and Grisolía S: Ammonium choride-induced alterations in growth kinetics and ultrastructure of murine neuroblastoma cells. A flow cytometric and stereologic study. Virchows Arch. (Cell Pathol.) 50: 271–283, 1986.
O’Connor JE, Gollerkeri A and Kimler BF: Flow cytometric analysis of cytotoxic effects of ammonia on murine neuroblastoma. Bas. Appl. histochem. 32: 379, 1988.
O’Connor JE, Kimler BF, Gollerkeri A, Costell M and Grisolía S: Flow cytometric analysis of ammonia toxicity in cultured murine neuroblastoma cells. Cytometry (in press), 1990.
Petit PX, Costell M, O’Connor JE and Matthes M: Flow cytometry analysis of Rhl23 membrane potential related fluorescence in isolated mitochondria from hyperammonemic mice. Biol. Cell 67: 29a, 1989.
Recknagel OR: Carbon tetrachloride hepatotoxicity. Pharmacol. Rev. 19: 145–208, 1967.
Meister A and Anderson ME: Glutathione. Ann. Rev. Biochem. 52: 711–760, 1983.
O’Connor JE, Costell M, Miguez MP and Grisolía S: Altera-ciones del metabolismo hepético de los acidos grasos en 1a hiperamonemia crónica experimental. Pharmacia Mediterranea 16: 846–857,1986.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
O’Connor, J.E., Costell, M. (1990). New Roles of Carnitine Metabolism in Ammonia Cytotoxicity. In: Grisolía, S., Felipo, V., Miñana, MD. (eds) Cirrhosis, Hepatic Encephalopathy, and Ammonium Toxicity. Advances in Experimental Medicine and Biology, vol 272. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5826-8_12
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5826-8_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5828-2
Online ISBN: 978-1-4684-5826-8
eBook Packages: Springer Book Archive